Switch to
More onapp

Bliss GVS Pharma Ltd

BLISSGVS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹845 cr, stock is ranked 1,124
Moderate RiskStock is 2.25x as volatile as Nifty
79.601.60 (-1.97%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹845 cr, stock is ranked 1,124
Moderate RiskStock is 2.25x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
56.27
PB RatioPB Ratio
1.00
Dividend YieldDiv. Yield
0.61%
Sector PESector PE
34.26
Sector PBSector PB
4.19
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bliss GVS Pharma Limited is engaged in developing, manufacturing and marketing pharmaceutical formulations.

Financial TrendFinancial statements 

2019202020212022936.20728.50597.43778.94123.7397.2668.5115.03
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Copy of Newspaper Publication 
Announced OnJan 30, 2023

Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshakti a Regional Daily, on January 26, 2023. | Download

Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshakti a Regional Daily, on January 26, 2023. | Download

Financial Result Updates 
Announced OnJan 24, 2023

Bliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022. | Download

Bliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022. | Download

Cash Dividend 
Ex. DateJun 20, 2022

Final • Div/Share: ₹ 0.5

See all events